Skip to main content

Table 1 Patient characteristics and tumor characteristics according to first and non-first pregnancy subgroup

From: Clinical features and survival of pregnancy-associated breast cancer: a retrospective study of 203 cases in China

Endocrine therapy

    

0.281

Yes

45

57.0

59

47.6

 

No

34

43.0

61

49.2

 

Target therapy

    

0.757

Yes

17

21.5

29

23.4

 

No

62

78.5

95

76.6

 
  1. Abbreviations: HR Hormone receptor, HER-2 Human epidermal growth factor receptor-2, IDC Invasive ductal carcinoma, DCIS Ductal carcinoma in situ, ILC Invasive lobular carcinoma, SLNB Sentinel lymph node biopsy, ALND Axillary lymph node dissection, pCR Pathological complete remission
  2. (a): HR positive: ER (estrogen receptor) positive or/and PR (progesterone receptor) positive
  3. (b): Pearson Chi-square tests between first pregnancy group and non-first pregnancy group
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us